Daniel Yilma in Proceedings of International Conference on Plasmodium vivax

Elmer Llanos-Cuentas ¹ ; Marcus Vinícius Guimarães de Lacerda ² ; Raul Chuquiyauri ¹ ; David Saunders ³ ; Lon Chanthap ³ ; Daniel Yilma ⁴ ; Rezika Mohammed ⁵ ; Srivicha Krudsood ⁶ ; Dhelio Pereira ⁷ ; Fe Espino ⁸ ; Harald Noedl ⁹ ; Brian Angus ¹⁰ ; Joerg-Peter Kleim ¹¹ ; Stephan Duparc ¹² ; Sion W. Jones ¹¹ ; Elizabeth Hardaker ¹¹ ; Khadeeja Mohamed ¹¹ ; Kim Fletcher ¹¹ ; Jhon Breton ¹³ ; Jutin A Green ¹¹ ; Cletus O. Ugwuegbulam ¹¹ ; Gavin CKW Koh ¹¹

¹ Universidad Peruana Cayetano Heredia, Lima, Peru ;

² Instituto Leonidas e Maria Deane, Fiocruz, Manaus, Brazil ;

³ Armed Forces Research Institute of Medical Sciences, Thailand ;

⁴ Jimma University, Ethiopia ;

⁵ University of Gondar, Ethiopia ;

⁶ Mahidol University, Thailand ;

⁷ Centro de Pesquisa em Medicina Tropical de Rondonia, Brazil ;

⁸ Research Institute for Tropical Medicine, Philippines ;

⁹ University of Vienna, Austria ;

¹⁰ University of Oxford, United Kingdom ;

¹¹ GlaxoSmithKline, United Kingdom ;

¹² Medicines for Malaria Venture, Switzerland ;

¹³ GlaxoSmithKline, USA

Vol.1, 2017 -

63246

Proceedings of International Conference on Plasmodium vivax